I agree that this site is using cookies. You can find further informations here.
X
Caron Jacobson
222  results:
Search for persons X
?
1

Disseminated Mycobacterium avium complex Infection followin..:

Little, Jessica S ; Hurtado, Rocio M ; Boire, Nicholas...
Open Forum Infectious Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

The treatment of follicular lymphoma with CD19-directed chi..:

Jacobs, Ryan ; Jacobson, Caron
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Outcomes in Patients (pts) with R/R Large B-Cell Lymphoma (..:

Caimi, Paolo ; Schuster, Stephen J. ; Nastoupil, Loretta J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S188-S189 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Three-year follow-up analysis of axicabtagene ciloleucel in..:

Neelapu, Sattva S. ; Chavez, Julio C. ; Sehgal, Alison R....
Blood.  143 (2024)  6 - p. 496-506 , 2024
Link: https://doi.org/10.1182/..
 
?
5

Clinical Practice Recommendations for Hematopoietic Cell Tr..:

Iqbal, Madiha ; Kumar, Ambuj ; Dreger, Peter...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

Long-term outcomes of patients with large B-cell lymphoma t..:

Oluwole, Olalekan O. ; Forcade, Edouard ; Muñoz, Javier...
Bone Marrow Transplantation.  59 (2024)  3 - p. 366-372 , 2024
Link: https://doi.org/10.1038/..
 
?
7

Radiotherapy as a bridging strategy for patients with relap..:

Ababneh, Hazim S. ; Ng, Andrea K. ; Frigault, Matthew J...
American Journal of Hematology.  99 (2024)  9 - p. 1837-1840 , 2024
Link: https://doi.org/10.1002/..
 
?
8

Durable Efficacy and Manageable Safety in Patients Age ≥75 ..:

Landsburg, Daniel J. ; Heim, Michael ; Moskop, Amy...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S187-S188 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Real-World Tisagenlecleucel Outcomes in Richter-Transformed..:

Shadman, Mazyar ; Frigault, Matthew J. ; Foley, Stephen Ronan...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S189-S190 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Outcomes of subsequent antilymphoma therapies after second-..:

Ghobadi, Armin ; Munoz, Javier ; Westin, Jason R....
Blood Advances.  8 (2024)  11 - p. 2982-2990 , 2024
Link: https://doi.org/10.1182/..
 
?
11

Checkpoints: roadblocks or repairs for the CAR-T journey?:

Crombie, Jennifer L. ; Jacobson, Caron A.
Blood Advances.  8 (2024)  2 - p. 468-469 , 2024
Link: https://doi.org/10.1182/..
 
?
12

Real-world and clinical trial outcomes in large B-cell lymp..:

Locke, Frederick L. ; Siddiqi, Tanya ; Jacobson, Caron A....
Blood.  143 (2024)  26 - p. 2722-2734 , 2024
Link: https://doi.org/10.1182/..
 
?
13

Benefit of axicabtagene ciloleucel versus chemoimmunotherap..:

Lunning, Matthew A. ; Wang, Hai‐lin ; Hu, Zhen‐Huan...
American Journal of Hematology.  99 (2024)  5 - p. 880-889 , 2024
Link: https://doi.org/10.1002/..
 
?
14

A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ci..:

Ghione, Paola ; Palomba, M. Lia ; Ray, Markqayne D....
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
15

Five-year follow-up of a phase 2 study of ibrutinib plus fl..:

Ahn, Inhye E. ; Brander, Danielle M. ; Ren, Yue...
Blood Advances.  8 (2024)  4 - p. 832-841 , 2024
Link: https://doi.org/10.1182/..
 
1-15